Is Eleven Coagulation Heaven? Clots, COVID and Anticoagulation (part 2)

Submitted by Beatrice on Thu, 03/06/2021 - 09:58

Medicine moves quickly when it has to. In my previous post I mentioned clinical trials of DOACs for patients with COVID-19, but we already know that this approach is proving to be futile. We’ve seen the spectre of blood clots appear as a side effect from the vaccine, and we now think we know how they occur.

Democratising access to educational materials

Submitted by Jan Ash on Tue, 01/06/2021 - 08:08

Attending medical conferences is a great way for healthcare professionals to learn about the latest advances in therapies and treatments for diseases in their chosen area. Not only can Specialists listen to lectures delivered by world-renowned Key Opinion Leaders, with whom they may not normally come into contact, but they can speak directly to exhibitors, listen to abstracts, read posters, attend workshops… the benefits go on. However, attendance at these events comes at a price, both literally and figuratively.

Virtual preceptorships: Supporting newly qualified Specialists in an online world

Submitted by Jan Ash on Mon, 17/05/2021 - 08:39

Preceptorship meetings are a fantastic way for newly qualified healthcare professionals to build on the education they received during formal training and continue the learning process. They help smooth the transition from student to Specialist and build confidence in being able to work autonomously – all of which leads to increased quality of care and patient satisfaction.

What Do an Otter and a Medical Writer Have in Common?

Submitted by Beatrice on Mon, 26/04/2021 - 16:22

How long have you worked in Med Comms?

I have been working in the healthcare industry for ~4 years, after completing my MSc in Biomedical Science. In a former life, I worked for pharmaceutical companies in clinical research departments. I’ve spent the last ~2 years working as a Medical Writer at Med Comms agencies.

How long have you worked at AS&K?

Multimarker approaches to Heart Failure therapy and beyond

Submitted by Jan Ash on Tue, 13/04/2021 - 07:44

Heart failure (HF) is a pressing and illusive public health epidemic. Nearly 50% of all HF cases involve HFpEF — to which there is no defined therapy (1). As such, refining prediction and treatment of HF is a crucial step in alleviating high morbidity and mortality (2). The development of novel clinical tools and therapies that assist in the diagnosis and management of HF, such as the use of biomarkers, are essential to improving patient outcomes.

No Zoom Please, We’re Tired

Submitted by Beatrice on Wed, 07/04/2021 - 07:51

How to mitigate Zoom fatigue

Back at the start of 2020 I had never heard of Zoom. If I had to join a meeting remotely, I would ask the host to dial me in. At a push I’d use Skype, but I would never, ever, turn on my video!

But then a year ago, if I joined a meeting remotely, I’d often miss half the conversation, all the whiteboard action, and spend most of the time asking people to repeat what they said.